Rishitin is a sesquiterpenoid phytoalexin produced by potato plants in response to pathogen attack. It has antifungal and antibacterial properties and plays a role in the plant's defense against diseases. Rishitin is synthesized through the mevalonate pathway, starting from farnesyl pyrophosphate. It is of interest to researchers because of its potential use in developing new fungicides and antibiotics. Studies on rishitin focus on understanding its biosynthesis, its mode of action, and its potential application in agriculture.'
rishitin: bicyclic norsesquiterpene detected in potato tubers infected with Phytophthora infestans; RN given refers to cpd without isomeric designation; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
ID Source | ID |
---|---|
PubMed CID | 108064 |
CHEBI ID | 8870 |
SCHEMBL ID | 1840048 |
MeSH ID | M0053670 |
Synonym |
---|
2,3-naphthalenediol, 1,2,3,4,5,6,7,8-octahydro-1-methyl-7-(1-methylethenyl)-, (1s,2r,3r,7r)- |
inchi=1/c14h22o2/c1-8(2)10-4-5-11-7-13(15)14(16)9(3)12(11)6-10/h9-10,13-16h,1,4-7h2,2-3h3/t9-,10+,13+,14+/m0/s |
7-isopropenyl-1-methyl-1,2,3,4,5,6,7,8-octahydro-naphthalene-2,3-diol |
rel-(1r,2s,3s,7s)-7-isopropenyl-1-methyl-1,2,3,4,5,6,7,8-octahydronaphthalene-2,3-diol |
rishitin |
C09715 , |
18178-54-6 |
(1s,2r,3r,7r)-1-methyl-7-prop-1-en-2-yl-1,2,3,4,5,6,7,8-octahydronaphthalene-2,3-diol |
(-)-rishitin |
(1alpha,2beta,3alpha,7beta)-(-)-1,2,3,4,5,6,7,8-octahydro-1-methyl-7-(1-methylethenyl)-2,3-naphthalenediol |
unii-fqy1k3hr10 |
2,3-naphthalenediol, 1,2,3,4,5,6,7,8-octahydro-1-methyl-7-(1-methylethenyl)-, (1alpha,2beta,3alpha,7beta)-(-)- |
fqy1k3hr10 , |
7-isopropenyl-1-methyl-1,2,3,4,5,6,7,8-octahydro-2,3-naphthalenediol |
SCHEMBL1840048 |
CHEBI:8870 |
(1s,2r,3r,7r)-7-isopropenyl-1-methyl-1,2,3,4,5,6,7,8-octahydronaphthalene-2,3-diol |
DTXSID60171184 |
Q27108165 |
risbitin |
Class | Description |
---|---|
polyol | A compound that contains two or more hydroxy groups. |
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Pathway | Proteins | Compounds |
---|---|---|
sesquiterpenoid phytoalexins biosynthesis | 2 | 13 |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 2 (25.00) | 18.7374 |
1990's | 3 (37.50) | 18.2507 |
2000's | 2 (25.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (12.50) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (25.54) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 8 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |